We performed a retrospective screening of 428 serum samples for anti-SARS-CoV-2 immunoglobulin during a period of low prevalence. Employing two different serological tests yielded discrepant results for 10 samples; highlighting an increased risk of potential false positive results and the need for further confirmatory testing before publication of data.
All Keywords
【저자키워드】 SARS-CoV-2, Serological testing, low prevalence,
【저자키워드】 SARS-CoV-2, Serological testing, low prevalence,